The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias
Abstract
The remarkable phenotypic diversity of the beta-thalassaemias reflects the heterogeneity of mutations at the beta-globin locus, the action of many secondary and tertiary modifiers, and a wide range of environmental factors. It is likely that phenotype-genotype relationships will be equally complex in the case of many monogenic diseases. These findings highlight the problems that might be encountered in defining the relationship between the genome and the environment in multifactorial disorders, in which the degree of heritability might be relatively low and several environmental agents are involved. They also emphasize the value of an understanding of phenotype-genotype relationships in designing approaches to gene therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients affected by sickle cell anemia and β-thalassemia experience a milder course of the disease if they express elevated levels of fetal hemoglobin in adulthood (Platt et al., 1994; Weatherall, 2001).”
From Reactivation of developmentally silenced globin genes by forced chromatin looping (2014) · cites this paper as Weatherall, 2001
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
The metabolic and molecular bases of inherited disease
Chen, Y.-T. (2001) · Medical Entomology and Zoology · Cited by 6,928
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D. P., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,573
Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria
McGuire, W. L., Hill, A. V. S., Allsopp, C. E. M., Greenwood, B. M., & Kwiatkowski, D. P. (1994) · Nature · doi:10.1038/371508a0 · Cited by 1,166
Pathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154 · cited 1×
“At this level of sickleable cells, or above, vaso-occlusive episodes are commo”
BackgroundWeatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,077
Messenger RNA degradation in eukaryotes
Sachs, A. B. (1993) · Cell · doi:10.1016/0092-8674(93)80043-e · Cited by 846
(1973) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 808
Global prevalence of putative haemochromatosis mutations.
Merryweather‐Clarke, A. T., Pointon, J. J., Shearman, J. R., & Robson, K. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.4.275 · Cited by 781
The Molecular Basis of Blood Diseases.
(1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-6-950_3 · Cited by 640
Research works printed but not linked: 6
- Huisman, T. H. J., Carver, M. F. H. & Efremov, G. D. A Syllabus of Human Hemoglobin Variants (Sickle Cell Foundation, Augusta, Georgia, 1998).
- Weatherall, D. J. Pathophysiology of thalassaemia. Clin. Haematol. 11 , 127–146 (1998).
- Huisman, T. H. J., Carver, M. F. H. & Baysal, E. A Syllabus of Thalassemia Mutations 1– 309 (The Sickle Cell Anemia Foundation, Augusta, Georgia, 1997).A complete and detailed catalogue of all the published thalassaemia mutations and their geographical distribution up to 1997.
- Kazazian, H. H., Dowling, C. E., Hurwitz, R. L., Coleman, M. & Adams, J. G. I. Thalassemia mutations in exon 3 of the β-globin gene often cause a dominant form of thalassemia and show no predilection for malarial-endemic regions of the world. Am. J. Hum. Genet. 45, A242 ( 1989).
- Thein, S. L. in Baillière's Clinical Haematology. International Practice and Research: The Haemoglobinopathies (eds Higgs, D. R. & Weatherall, D. J.) 151–176 (Baillière Tindall, London, 1993).
- Thein, S. L. & Weatherall, D. J. in Hemoglobin Switching. B. Cellular and Molecular Mechanisms (eds Stamatoyannopoulos, G. & Nienhuis, A. W.) 97–112 (Alan R. Liss, New York, 1989).
Cited by
Sorted by citations
Items 101–200 of 692
The Land Between Mendelian and Multifactorial Inheritance
Burghes, A. H. M., Vaessin, H., & de la Chapelle, A. (2001) · Science · doi:10.1126/science.1065930 · Cited by 76
Kakhniashvili, D. G., Griko, N. B., Bulla, L. A., & Goodman, S. R. (2005) · Experimental Biology and Medicine · doi:10.1177/153537020523001102 · Cited by 75
Verra, F., Mangano, V. D., & Modiano, D. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01106.x · Cited by 81
Forecasting Hemoglobinopathy Burden Through Neonatal Screening in Omani Neonates
Alkindi, S. S. A., Zadjali, S. A., Madhani, A. A., Daar, S., Al-Haddabi, H., Abri, Q. A., Gravell, D., Berbar, T., Pravin, S., Pathare, A. V., et al. (2010) · Hemoglobin · doi:10.3109/03630261003677213 · Cited by 74
Melzer, D. R., & Zimmern, R. (2002) · BMJ · doi:10.1136/bmj.324.7342.863 · Cited by 74
A compendium of inborn errors of metabolism mapped onto the human metabolic network
Sahoo, S., Franzson, L., Jónsson, J. J., & Thiele, I. (2012) · Molecular BioSystems · doi:10.1039/c2mb25075f · Cited by 71
Disorders of the synthesis of human fetal hemoglobin
Manca, L., & Masala, B. (2008) · IUBMB Life · doi:10.1002/iub.4 · Cited by 70
Development of a microfluidic biochip for online monitoring of fungal biofilm dynamics
Richter, L., Stepper, C., Mak, A. C., Reinthaler, A., Heer, R., Kast, M., Brückl, H., & Ertl, P. (2007) · Lab on a Chip · doi:10.1039/b708236c · Cited by 70
Nuntakarn, L., Fucharoen, S., Fucharoen, G., Sanchaisuriya, K., Jetsrisuparb, A., & Wiangnon, S. (2008) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2008.09.002 · Cited by 70
Crippa, S., Rossella, V., Aprile, A., Silvestri, L., Rivis, S., Scaramuzza, S., Pirroni, S., Avanzini, M. A., Ricci, L. B., Hernández, R. J., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123191 · Cited by 67
Thalassemia: An Overview of 50 Years of Clinical Research
Sankaran, V. G., & Nathan, D. G. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.009 · Cited by 68
The transfusion management of beta thalassemia in the United States
Lal, A., Wong, T. E., Keel, S., Pagano, M. B., Chung, J. H., Kamdar, A., Rao, L. B., Ikeda, A. K., Puthenveetil, G., Shah, S. J., et al. (2021) · Transfusion · doi:10.1111/trf.16640 · Cited by 68
Transcriptional silencing of fetal hemoglobin by BCL11A
Sankaran, V. G., Xu, J., & Orkin, S. H. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05574.x · Cited by 68
Tallack, M. R., & Perkins, A. C. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835f59ba · Cited by 69
Vichinsky, E. P. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05572.x · Cited by 67
Genetics of Essential Hypertension
Barlassina, C., Lanzani, C. L., Manunta, P., & Bianchi, G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032524.13069.88 · Cited by 69
Steckel, R. H., Larsen, C. S., Sciulli, P. W., & Walker, P. L. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108379830.016 · Cited by 64
Recent trends in the gene therapy of β-thalassemia
Gambari, R., Finotti, A., Breda, L., Lederer, C. W., Bianchi, N., Zuccato, C., Klenathous, M., & Rivella, S. (2015) · Journal of Blood Medicine · doi:10.2147/jbm.s46256 · Cited by 80
The Molecular Pathology of β-Thalassemia in Turkey: The Boğaziçi University Experience
Başak, A. N. (2007) · Hemoglobin · doi:10.1080/03630260701296735 · Cited by 62
Thalassemia: current approach to an old disease
Lo, L., & Singer, S. T. (2002) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(02)00088-3 · Cited by 61
ABCA4 gene analysis in patients with autosomal recessive cone and cone rod dystrophies
Kitiratschky, V. B. D., Grau, T., Bernd, A. S., Zrenner, E., Jägle, H., Renner, A. B., Kellner, U., Rudolph, G., Jacobson, S. G., Cideciyan, A. V., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.23 · Cited by 61
The backbone of Europe : health, diet, work and violence over two millennia
Steckel, R. H., Larsen, C. S., Roberts, C. A., & Baten, J. (2019) · doi:10.15496/publikation-27417 · Cited by 62
Angiotensin-Converting Enzyme I/D and α-Adducin Gly460Trp Polymorphisms
Li, Y., Zagato, L., Kuznetsova, T., Tripodi, G., Zerbini, G., Richart, T., Thijs, L., Manunta, P., Wang, J., Bianchi, G., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.085498 · Cited by 59
Wang, Q., Lu, Q., & Zhao, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00149 · Cited by 62
New therapeutic targets in transfusion-dependent and -independent thalassemia
Cappellini, M. D., & Motta, I. (2017) · Hematology · doi:10.1182/asheducation-2017.1.278 · Cited by 57
Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia
Quinn, C. T., Shull, E. P., Ahmad, N., Lee, N. J., Rogers, Z. R., & Buchanan, G. R. (2006) · Blood · doi:10.1182/blood-2006-02-005082 · Cited by 56
Human Races: Classifying People vs Understanding Diversity
Barbujani, G. (2005) · Current Genomics · doi:10.2174/1389202054395973 · Cited by 56
Bianchi, G. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00441.2005 · Cited by 56
Defining the Pathogenicity of Optineurin in Juvenile Open-Angle Glaucoma
Willoughby, C. E., Chan, L. L. Y., Herd, S., Billingsley, G. D., Noordeh, N., Levin, A. V., Buys, Y. M., Trope, G. E., Sarfarazi, M., & Héon, E. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0107 · Cited by 56
Role of Alpha Hemoglobin‐Stabilizing Protein in Normal Erythropoiesis and β‐Thalassemia
Weiss, M. J., ZHOU, S., Feng, L., Gell, D. A., Mackay, J. P., Shi, Y., & Gow, A. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.013 · Cited by 53
Heritability of the Human Infectious Reservoir of Malaria Parasites
Lawaly, Y. R., Sakuntabhai, A., Marrama, L., Konaté, L., Phimpraphi, W., Sokhna, C., Tall, A., Sarr, F. D., Peerapittayamongkol, C., Cheepsunthorn, C. L., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011358 · Cited by 53
Unraveling the Pathogenesis of Type 1 Diabetes with Proteomics: Present And Future Directions*
Sparre, T., Larsen, M., Heding, P., Karlsen, A., Jensen, O., & Pociot, F. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r500002-mcp200 · Cited by 54
Ineffective Erythropoiesis in β-Thalassaemia: Key Steps and Therapeutic Options by Drugs
Longo, F., Piolatto, A., Ferrero, G. B., & Piga, A. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137229 · Cited by 53
Lin, M., Zhong, T., Chen, Y., Wang, J., Wu, J.-R., Lin, F., Tong, X., Yang, H.-T., Hu, X., Hu, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101505 · Cited by 52
Lisowski, L., & Sadelain, M. (2007) · Blood · doi:10.1182/blood-2007-08-108647 · Cited by 52
Carrier screening and genetic counselling in β-thalassemia
Cao, A. (2002) · International Journal of Hematology · doi:10.1007/bf03165098 · Cited by 52
Genetic modifiers in human development and malformation syndromes, including chaperone proteins
Slavotinek, A. M. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg099 · Cited by 52
Reliability of DHPLC in mutational screening of ?-globin (HBB) alleles
Colosimo, A., Guida, V., Luca, A. D., Cappabianca, M. P., Bianco, I., Palka, G., & Dallapiccola, B. (2002) · Human Mutation · doi:10.1002/humu.10046 · Cited by 52
Gene therapy for hemoglobinopathies: progress and challenges
Dong, A., Rivella, S., & Breda, L. (2013) · Translational research · doi:10.1016/j.trsl.2012.12.011 · Cited by 52
Srichairatanakool, S., Ounjaijean, S., Thephinlap, C., Khansuwan, U., Phisalpong, C., & Fucharoen, S. (2006) · Hemoglobin · doi:10.1080/03630260600642666 · Cited by 51
A humanized mouse model for a common β0-thalassemia mutation
Jamsai, D., Zaibak, F., Khongnium, W., Vadolas, J., Voullaire, L. E., Fowler, K. J., Gazeas, S., Fucharoen, S., Williamson, R., & Ioannou, P. A. (2005) · Genomics · doi:10.1016/j.ygeno.2004.11.016 · Cited by 50
The Selective Values of Alleles in a Molecular Network Model Are Context Dependent
Peccoud, J., Velden, K. V., Podlich, D., Winkler, C., Arthur, L., & Cooper, M. (2004) · Genetics · doi:10.1534/genetics.166.4.1715 · Cited by 50
Excitation-Inhibition Discoordination in Rodent Models of Mental Disorders
Fenton, A. A. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.013 · Cited by 49
Teofili, L., Papacci, P., Orlando, N., Bianchi, M., Molisso, A., Purcaro, V., Valentini, C. G., Giannantonio, C., Serrao, F., Chiusolo, P., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16851 · Cited by 49
Therapeutic Options for Patients with Severe β-Thalassemia: The Need for Globin Gene Therapy
Sadelain, M., Boulad, F., Galanello, R., Giardina, P. J., Locatelli, F., Maggio, A., Rivella, S., Rivière, I., & Tisdale, J. F. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.151 · Cited by 49
A humanized BAC transgenic/knockout mouse model for HbE/β-thalassemia
Jamsai, D., Zaibak, F., Vadolas, J., Voullaire, L. E., Fowler, K. J., Gazeas, S., Peters, H. L., Fucharoen, S., Williamson, R., & Ioannou, P. A. (2006) · Genomics · doi:10.1016/j.ygeno.2006.03.009 · Cited by 49
Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia
Sadelain, M. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219658.57915.d4 · Cited by 49
Infrared Spectroscopic Identification of β-Thalassemia
Liu, K., Tsang, K. S., Li, C. K., Shaw, R. A., & Mantsch, H. H. (2003) · Clinical Chemistry · doi:10.1373/49.7.1125 · Cited by 49
Genetic disruption of the KLF1 gene to overexpress the γ‐globin gene using the CRISPR/Cas9 system
Shariati, L., Khanahmad, H., Salehi, M., Hejazi, Z., Rahimmanesh, I., Tabatabaiefar, M. A., & Modarressi, M. H. (2016) · The Journal of Gene Medicine · doi:10.1002/jgm.2928 · Cited by 48
Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches
Sripichai, O., & Fucharoen, S. (2016) · Expert Review of Hematology · doi:10.1080/17474086.2016.1255142 · Cited by 48
Mahdieh, N., & Rabbani, B. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.07.001 · Cited by 47
Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease
Chonat, S., & Quinn, C. T. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-7299-9_3 · Cited by 48
Molecular characterization of α- and β-thalassemia in the Yulin region of Southern China
he, S. T., Li, J., Li, D. M., Yi, S., Lu, X., Luo, Y., Liang, Y. L., Feng, C., Chen, B., Zheng, C., et al. (2018) · Gene · doi:10.1016/j.gene.2018.02.058 · Cited by 47
Chuncharunee, S., Teawtrakul, N., Siritanaratkul, N., & Chueamuangphan, N. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214148 · Cited by 53
Genetic control of susceptibility to bacterial infections in mouse models
Lam-Yuk-Tseung, S., & Gros, P. (2003) · Cellular Microbiology · doi:10.1046/j.1462-5822.2003.00276.x · Cited by 47
Yanpanitch, O.-U., Hatairaktham, S., Charoensakdi, R., Panichkul, N., Fucharoen, S., Srichairatanakool, S., Siritanaratkul, N., & Kalpravidh, R. W. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/537954 · Cited by 46
dos Santos, C. O., Zhou, S., Secolin, R., Wang, X., da Cunha, A. F., Higgs, D. R., Kwiatkowski, J. L., Thein, S. L., Gallagher, P. G., Costa, F. F., et al. (2007) · American Journal of Hematology · doi:10.1002/ajh.21041 · Cited by 45
The role of HFE mutations on iron metabolism in beta-thalassemia carriers
Martins, R., Picanço, I., Fonseca, A., Ferreira, L. G., Rodrigues, O., Coelho, M., Seixas, T., Miranda, A., Nunes, B., Costa, L. M. G., et al. (2004) · Journal of Human Genetics · doi:10.1007/s10038-004-0202-z · Cited by 44
Germline Epimutation: A Basis for Epigenetic Disease in Humans
Martin, D. I. K., Ward, R. L., & Suter, C. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.009 · Cited by 44
Recent Advances in β-Thalassemias
Cao, A., Moi, P., & Galanello, R. (2011) · Pediatric Reports · doi:10.4081/pr.2011.e17 · Cited by 44
Yin, H., Yuan, X., Luo, L., Lu, Y., Qin, B., Zhang, J., Shi, Y., Zhu, C., Yang, J., Li, X., et al. (2020) · Advanced Science · doi:10.1002/advs.201903381 · Cited by 42
The search for genetic variants predisposing women to endometriosis
Di, W. J., & Guo, S. (2007) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328235a5b4 · Cited by 43
Progress Toward the Genetic Treatment of the β‐Thalassemias
Sadelain, M., Lisowski, L., Samakoglu, S., Rivella, S., May, C., & Rivière, I. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.010 · Cited by 43
Antoniani, C., Romano, O., & Miccio, A. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0192 · Cited by 50
Recent trends for novel options in experimental biological therapy of β-thalassemia
Finotti, A., & Gambari, R. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.927434 · Cited by 40
The regulation of human globin promoters by CCAAT box elements and the recruitment of NF-Y
Martyn, G. E., Quinlan, K. G. R., & Crossley, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.10.002 · Cited by 41
Alpha-thalassaemia and population health in Southeast Asia
Chui, D. H. K. (2005) · Annals of Human Biology · doi:10.1080/03014460500075084 · Cited by 41
Beta-Thalassaemia Intermedia: Evaluation of Endocrine and Bone Complications
Baldini, M., Marcon, A., Cassin, R., Ulivieri, F. M., Spinelli, D., Cappellini, M. D., & Graziadei, G. (2014) · BioMed Research International · doi:10.1155/2014/174581 · Cited by 40
Circulatory, Reticuloendothelial, and Hematopoietic Disorders
Grauer, A. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809738-0.00014-4 · Cited by 42
Chou, Y., Chen, R.-L., Lai, Z.-S., Song, J., Chao, Y., & Shen, C.-K. J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00035-15 · Cited by 39
Weatherall, D. J. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153500 · Cited by 39
Bailey, S., & Tóth, M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-04.2004 · Cited by 38
The global problem of genetic disease
Weatherall, D. J. (2005) · Annals of Human Biology · doi:10.1080/03014460500075480 · Cited by 38
Retinal abnormalities in β-thalassemia major
Bhoiwala, D. L., & Dunaief, J. L. (2015) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2015.08.005 · Cited by 37
Alpha-Hemoglobin-Stabilizing Protein: An Erythroid Molecular Chaperone
Fávero, M. E., & Costa, F. F. (2011) · Biochemistry Research International · doi:10.1155/2011/373859 · Cited by 37
A large cohort of β+-thalassemia in Thailand: Molecular, hematological and diagnostic considerations
Yamsri, S., Singha, K., Prajantasen, T., Taweenan, W., Fucharoen, G., Sanchaisuriya, K., & Fucharoen, S. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.11.008 · Cited by 37
DNA-based nano-sized systems for pharmaceutical and biomedical applications
Nishikawa, M., Rattanakiat, S., & Takakura, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.006 · Cited by 37
Lin, M., Wen, Y.-F., Wu, J.-R., Wang, Q., Zheng, L., Liu, G., Huang, Y., Yang, H., Lin, F., Zhan, X.-F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055024 · Cited by 37
Modifier genes in Mendelian disorders: the example of hemoglobin disorders
Sankaran, V. G., Lettre, G., Orkin, S. H., & Hirschhorn, J. N. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05821.x · Cited by 37
Zuccato, C., Cosenza, L. C., Zurlo, M., Gasparello, J., Papi, C., D’Aversa, E., Breveglieri, G., Lampronti, I., Finotti, A., Borgatti, M., et al. (2022) · Therapeutic Advances in Hematology · doi:10.1177/20406207221100648 · Cited by 36
Current advances of CRISPR-Cas technology in cell therapy
Qiu, H.-Y., Ji, R.-J., & Zhang, Y. (2022) · Cell Insight · doi:10.1016/j.cellin.2022.100067 · Cited by 38
Genetic Benefits of Consanguinity Through Selection of Genotypes Protective Against Malaria
Denic, S., & Nicholls, M. G. (2007) · Human Biology · doi:10.1353/hub.2007.0030 · Cited by 36
A Review of the Molecular Diagnosis of Thalassemia
Gu, X., & Zeng, Y. (2002) · Hematology · doi:10.1080/1024533021000024102 · Cited by 36
Phenotypic expression of pyruvate kinase deficiency and protection against malaria in a mouse model
Min-Oo, G., Fortin, A., Tam, M.-F., Gros, P., & Stevenson, M. (2004) · Genes & Immunity · doi:10.1038/sj.gene.6364069 · Cited by 35
Thalassemia in the laboratory: pearls, pitfalls, and promises
Aliyeva, G., Asadov, C. D., Mammadova, T., Gafarova, S., & Abdulalimov, E. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0647 · Cited by 39
Current status of globin gene therapy for the treatment of β‐thalassaemia
Lisowski, L., & Sadelain, M. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07098.x · Cited by 41
Novel players in β-thalassemia dyserythropoiesis and new therapeutic strategies
Arlet, J., Dussiot, M., Moura, I. C., Hermine, O., & Courtois, G. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000231 · Cited by 40
Molecular analysis of α-thalassemia and β-thalassemia in Quanzhou region Southeast China
Zhuang, J., Jiang, Y., Wang, Y., Zheng, Y., Zhuang, Q., Wang, J., & Zeng, S. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-206179 · Cited by 34
Sguazzi, G. P., Muto, V., Tartaglia, M., Bertini, E., & Compagnucci, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413674 · Cited by 37
(2018) · Cambridge University Press eBooks · doi:10.1017/9781108379830 · Cited by 38
Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia
Quinn, C. T., & Miller, S. T. (2004) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2004.07.004 · Cited by 34
Multicenter Study of the Molecular Basis of Thalassemia Intermedia in Different Ethnic Populations
Verma, I. C., Kleanthous, M., Saxena, R., Fucharoen, S., Winichagoon, P., Raizuddin, S., Khan, S. N., Akbari, M. T., Izadyar, M., Kotea, N., et al. (2007) · Hemoglobin · doi:10.1080/03630260701641245 · Cited by 34
Aksoy, C., Guliyev, A., Kılıç, E., Uçkan, D., & Severcan, F. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0444 · Cited by 33
Regulation of Iron Absorption in Hemoglobinopathies
Rechavi, G., & Rivella, S. (2008) · Current Molecular Medicine · doi:10.2174/156652408786241401 · Cited by 32
Thalassemia in Sri Lanka: a progress report
Premawardhena, A. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh250 · Cited by 33
Pereira, C., Relvas, L., Bento, C., Abade, A., Ribeiro, L., & Manco, L. (2015) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2015.02.001 · Cited by 32
Gidalevitz, T., Wang, N., Deravaj, T., Alexander-Floyd, J., & Morimoto, R. I. (2013) · BMC Biology · doi:10.1186/1741-7007-11-100 · Cited by 32
Wu, G., Hua, L., Zhu, J., Mo, Q., & Xu, X. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04431.x · Cited by 32
Mehrdadi, S. (2023) · Advanced Pharmaceutical Bulletin · doi:10.34172/apb.2024.016 · Cited by 43
Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in β‐thalassemia
Sadelain, M., Rivière, I., Wang, X., Boulad, F., Prockop, S. E., Giardina, P. J., Maggio, A., Galanello, R., Locatelli, F., & Yannaki, E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05597.x · Cited by 34
Metadata
- Authors
- Weatherall, D. J.
- Affiliations
- John Radcliffe Hospital (GB)
- Corresponding author
- Weatherall, D. J.
- Venue
- Nature Reviews Genetics
- Published
- 2001-04
- Volume
- 2
- Issue
- 4
- Pages
- 245-255
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W1598569053
- Cited by
- 692
- References
- 79
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 27 · 2023: 32 · 2022: 16 · 2021: 31 · 2020: 27 · 2019: 28 · 2018: 39 · 2017: 32 · 2016: 33 · 2015: 29 · 2014: 26 · 2013: 35 · 2012: 26
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- genotype-phenotype correlation, beta-thalassemia, monogenic disorders, genetic modifiers, environmental factors, heritability, complex diseases, gene therapy
- MeSH terms
- Alleles, Bilirubin, Bone Diseases, Environment, Genes, Dominant, Genes, Recessive, Multigene Family, Genotype, Hemoglobins, Humans, Iron, Mutation, Phenotype, Thalassemia, Genetic Variation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review